What's Happening?
MedTech Innovator, a leading accelerator for medical technology startups, has unveiled its 2026 Accelerator Cohort, comprising 65 companies selected from 1,835 global applicants. Alongside this announcement, MedTech Innovator introduced the MTI Index,
a new platform that tracks and recognizes the most promising medtech companies. The MTI Index serves as a benchmark for investors and health systems to discover and engage with innovative startups. The 2026 cohort will participate in a four-month program designed to accelerate their path to market success in the U.S., culminating in a series of showcases and competitions for $800,000 in funding.
Why It's Important?
The launch of the MTI Index and the selection of the 2026 cohort highlight the growing emphasis on innovation in the medtech sector. By providing a structured platform for startups to gain visibility and access to resources, MedTech Innovator is playing a crucial role in de-risking medtech innovation. This initiative not only supports the growth of promising companies but also enhances the development of new medical technologies that can improve patient care. The MTI Index offers a valuable tool for stakeholders to track industry trends and identify key players in the medtech landscape.
What's Next?
The 2026 cohort will engage in the MTI accelerator program, which includes mentorship, industry visibility, and opportunities to compete for funding. The program will culminate in October with presentations at The MedTech Conference in Boston, where companies will showcase their innovations to industry leaders and investors. The MTI Index will continue to be updated, providing ongoing insights into the medtech sector's evolution and highlighting emerging trends and successful startups.
